Loading fund overlap…
15 of 306 unique stocks in common · Jaccard: 4.9%
A weighted portfolio overlap of 5.99% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹5.99 is allocated to the exact same companies at the same relative proportions. The schemes share 15 common holdings.
The largest overlapping asset in their portfolios is Gland Pharma, which commands a weight of 1.01% in ICICI Prudential India Opportunities Fund and 1.04% in . Holding both schemes increases your concentration in Gland Pharma rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in ICICI | in |
|---|---|---|
| Gland PharmaPharmaceuticals & Biotechnology | 1.01% | 1.04% |
| Kalpataru Projects InternationalConstruction | 0.76% | 0.72% |
| Sona Blw Precision ForgingsAuto Components | 0.72% | 1.65% |
| Aarti IndustriesChemicals & Petrochemicals | 0.55% | 0.49% |
| Affle 3iIT - Services | 0.89% | 0.46% |
| Indian Energy ExchangeCapital Markets | 0.58% | 0.43% |
| Tata ChemicalsChemicals & Petrochemicals | 0.37% | 0.45% |
| TBO TekLeisure Services | 0.95% | 0.27% |
| Chambal Fertilizers & ChemicalsFertilizers & Agrochemicals | 0.27% | 0.28% |
| KEC InternationalConstruction | 0.25% | 0.24% |
| Aditya Birla Lifestyle BrandsRetailing | 0.61% | 0.23% |
| CIE Automotive IndiaAuto Components | 0.23% | 0.23% |
| Cohance LifesciencesPharmaceuticals & Biotechnology | 0.22% | 0.34% |
| Brainbees SolutionsRetailing | 0.36% | 0.19% |
| PVR INOXEntertainment | 0.15% | 0.39% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on Aug 2026). Equity holdings only, ISIN-verified. Not investment advice.